Deep Genomics the company operates an AI-powered genetic medicine discovery tool with a focus on interpreting genetic variation. Leveraging high-throughput assays and advanced robotics systems, their AI platform generates billions of data points and constructs numerous engineered and validated machine learning systems. These systems play a crucial role in supporting drug development by assisting researchers in classifying, prioritizing, interpreting, and establishing connections among genetic variants, both natural and therapeutic.
$180M • 2021 • Series C
Deep Genomics sees AI taking center stage in medicine, surpassing the complexity of biology beyond human comprehension.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
Theranos was a consumer healthcare technology company that developed proprietary technologies for detecting, treating, and preventing blood-borne diseases Theranos raised $28.5M in 2006 with this deck.
Healx is transforming the rare disease treatment path for patients and their doctors by generating insights and enabling actionable recommendations that drive improved outcomes. Healx raised $56M in 2019 with this deck.
Cyclica provides tools for the entire pre-clinical drug discovery process Cyclica raised $17M in 2020 with this deck.
Fyodor Biotechnologies is a leading provider of innovative medical devices that change people’s lives. Fyodor Biotechnologies raised Undisclosed in 2018 with this deck.
No spam. Up to 2 emails/mo – only the good stuff!
Theranos